(ESAF). CBEC growing on plastic culture dishes or denatured collagen films were not stimulated by ESAF.
The mitogenic effect of ESAF was equally apparent when added to cells already attached to the native collagen substrate or when the collagen substrate was preincubated with ESAF before plating the cells. A floating collagen gel pre-incubated with ESAF in cultures of CBEC growing on plastic dishes did not stimulate cell growth. Our data indicate that the substrate influences cell behaviour and that CBEC only respond to ESAF when growing on a native collagen substrate.
THE GROWTH of a solid tumour depends on the establishment of an adequate blood supply (Algire & Chalkley, 1945; Folkman, 1974) . This is accomplished by the ingrowth of new capillaries from the surrounding host tissue in response to a diffusible substance produced by tumour cells and referred to as "tumour-angiogenesis factor" or TAF (Folkman et al., 1971) . Partially purified tumour extracts have been shown to contain angiogenic activity by the induction of blood vessel growth in various tissues in vivo (Folkman, 1974; Folkman et al., 1971; Gimbrone et al., 1974; Phillips et al., 1976) .
Although the mechanism by which the tumour-derived angiogenic factor induces capillary growth is not known, the overall process involves endothelial-cell hypertrophy (McAuslan & Hoffman, 1979) migration and proliferation (Cavallo et al., 1973;  (Aimbrone & Gullino, 1976; Ausprunk & Folkman, 1977) . Attempts to examine the mechanisms of TAF action on endothelial cells in vitro have often produced ambiguous results. For example, some partially purified tumour extracts may be mitogenic for endothelial cells in vitro, but either do not induce capillary growth in vivo (i.e. they are non-angiogenic) (MeAuslan & Hoffman, 1979) or their angiogenic capacity has not been reported (Fenselau & Mello, 1976) . Conversely other tumour extracts have been reported to contain angiogenic activity when assayed in vivo, but not to be mitogenic for endothelial cells in vitro (Phillips et al., 1976; Folkman & Contran, 1976) .
More recently, a low-mol.-wt factor (ESF) has been purified from sonicated tumour cells grown in tissue culture and shown to contain angiogenic activity in vivo, but not to be mitogenic for endothelial cells in vitro (McAuslan & Hoffman, 1979) . On the basis of these observations, tumour extracts have been postulated to contain two different factors, one which induces neovascularization in vivo (ESF) while the other stimulates endothelial-cell proliferation in vitro; the in vivo response to tumour extracts could then be due to a combination of these factors (McAuslan & Hoffman, 1979; and Folkman in Kumar, 1980) .
In a previous study we demonstrated that a crude tumour extract containing angiogenic activity in vivo was also mitogenic for endothelial cells in vitro, provided that the cells were growing on a native collagen substrate in the presence of platelet-release factors . In the present communication we report that a low-mol.-wt (LMW) compound isolated from tumour extracts and shown to be angiogenic in vivo (Weiss et al., 1979) is also mitogenic for endothelial cells on a native collagen substrate in vitro. Since we have also been able to obtain this factor from non-tumour sources (Brown et al., 1980) we have called it "endothelial-cell-stimulating angiogenesis factor" (ESAF).
MATERIALS AND METHODS
Cells.-Endothelial cells (CBEC) were isolated from cow brain white-matter capillaries as previously described . Primary cultures were grown in 75cm2 tissueculture Falcon flasks in Medium 199 supplemented with 10mM L-glutamine, 100 i.u. of penicillin and 100 jug streptomycin per ml and 16% foetal calf serum (FCS) .
Early-passage cultures of human embryo and adult fibroblasts were obtained from Dr D. Scott (Paterson Laboratories, Manchester).
Collagen substrates-.Type I collagen was extracted from rat-tail tendons and used to prepare heat-denatured collagen (gelatin) films and 3-dimensional gels of native collagen fibres in 35mm plastic Petri dishes (GibcoBiocult) as previously described (Schor & Court, 1979) .
Endothelial-cell-stimulating angiogenesis factor (ESAF).-Extracts of Walker 256 car-54 cinoma containing angiogenic activity (TAF) when assayed on the chick chorioallantoic membrane, were prepared as previously described (Phillips et al., 1976; ). An LMW compound ('200 daltons) with angiogenic activity (ESAF) was subsequently isolated from the tumour extract by affinity chromatography using antibody prepared against crude TAF coupled to Sepharose (Weiss et al., 1979) . Certain batches of ESAF were further purified by gel filtration on P2 biogel (Weiss et al., 1979) . The structure of the LMW ESAF isolated in this manner is currently under investigation. The yield of purified material is very small, and inert "fillers" (albumin or lactose) were routinely added to facilitate handling. The actual concentration of ESAF used in our experiments is therefore not known, although mass spectroscopy suggests that it is present only in pg quantities. Each batch of ESAF prepared in the above manner was tested for its ability to induce blood-vessel growth in the chick chorioallantoic membrane (Folkman, 1974; before being used in the experiments in vitro.
Determination of cell proliferation.-Confluent primary cultures of CBEC were washed twice with Dulbecco's phosphate-buffered saline "A" (BSS) and then incubated for 20 min at 37°C with 8 ml of 2mM ethyleneglycolbis (-aminoethyl ether) Sixteen to 24 h after plating, the medium was changed and ESAF dissolved in 100 ,ul BSS was added to the appropriate cultures. An equal volume of BSS was added to the controls.
In the experiments lasting more than 3 days the medium was changed and ESAF added every 2-3 days. was determined with a Coulter particle counter. Cells growing on plastic or gelatin films were removed for counting by trypsin (0 25% trypsin for 10 min at 370C). Cells growing on the 3 dimensional gels of native collagen were not completely detached by trypsin (Schor & Court, 1979) and, in order to recover the cells, these cultures were first treated with 1 ml of 0-2 mg/ml bacterial collagenase (Sigma, C-2139) in Medium 199 for 4-5 h to dissolve the collagen gel and the cells subsequently trypsinized and counted as previously described .
Triplicate cultures were used for every determination and the standard deviation was always less than 10% of the mean. The significance of differences between means was estimated by Student's t test.
RESULTS

Effect of ESAF on CBEC proliferation on different substrates
The growth characteristics of the cowbrain endothelial cells (CBEC) on plastic tissue-culture dishes and native collagen gels has been described . Briefly, cell behaviour on the native collagen gels differs from that on plastic dishes with respect to attachment characteristics (fewer cells remain attached to the native collagen gels 24 h after seeding a cell suspension) lag period before cell growth begins (longer on the native collagen gels) and growth rates (slower on the native collagen gels). As a result of the differences in the attachment and growth characteristics of the cells on the various substrates, twice as many CBEC were routinely plated on the collagen gels than on the plastic dishes in order to have comparable cell numbers attached 2-3 days later. Cell behaviour on gelatin films was similar to that on plastic for all the parameters studied.
The effect of the purified, LMW ESAF on the growth of CBEC on plastic dishes, gelatin films and native collagen gels is shown in Fig. 1 . Cells in medium containing 16% FCS were plated on the different substrates and 24 h later the medium (with unattached cells) was discarded and replaced with 2 ml of fresh growth medium. The number of attached cells was determined (Day 0 in Fig. 1 A-1* A-2 A-3* A-4 A-5* A-6* P-1 P-2 P-3 "ESAF + filler" (Kg/ml) )~- A low-mol.-wt angiogenic factor (ESAF) was isolated from rat Walker 256 carcinoma extracts by affinity chromatography ("A-" batches) and further gel filtration ("P-" batches) (Weiss, et al., 1979 that the filler alone (albumin or lactose) had no effect on cell proliferation.
Role of the substrate in the CBEC response to ESAF The mechanism by which ESAF stimulates CBEC proliferation in collagen gels is not understood. The following experiments were performed in order to determine whether cell proliferation is affected by the interaction of either ESAF or serum factors with the substrate.
The effects of preincubating the gels with serum are shown in Fig. 4 Fig. 4 , cell proliferation was greater on the gels pre-incubated with medium containing 16% FCS than on gels treated with serum-free medium. ESAF stimulated CBEC proliferation when the cells were growing on native collagen gels, irrespective of whether the growth rate was low (serum-free pre-incubated gels) or high (16% serum pre-incubated gels under the same conditions. The results obtained in a similar experiment in which gels were preincubated with ESAF rather than serum are shown in Fig. 5 . In this case, solutions of "preexposed" ESAF were prepared by incubating dishes containing the different substrates with a high concentration of ESAF in BSS for 24 h; this ESAF was then collected, diluted to the appropriate concentration (assuming no ESAF had been lost during the incubation) and stored at -20°C until required. Substrates were then prepared by incubating plastic dishes, gelatin films and native collagen gels for 24 h at 37°C with either serum-free medium or serum-free medium containing 10 jug of a particular batch of ESAF +filler (a concentration previously shown to stimu-3 late cell growth on collagen gels). All substrata were then washed x 8 with BSS over a 20h period. CBECin 16% serum medium were plated in these substrates fates. and incubated for a further 16 h. The conditions tested (data not shown). On native collagen gels, addition of t,he different ESAF solutions or preincubation of the gels with ESAF produced a similar increase in cell numbers after 3 days of incubation. In this particular experiment no lag period was observed on gels preincubated with ESAF, though this may be because cells on these gels had been in contact with it for 16 h when ESAF was added to the remaining cultures. In other experiments we have found that preincubation of the gels with ESAF does not shorten the lag period. These data indicate that ESAF binds to collagen and can stimulate CBEC proliferation in this state. Binding was not prevented by preincubation of the gels with l6% FCS before incubation with ESAF, and ESAF remained on the gels after extensive washing with BSS (for up to 48 h) or with 05m PBS (6 x 2ml) for 5 h.
The effects of ESAF pre-exposed to different substrates on CBEC proliferation suggest that it is not inactivated by exposure to plastic or denatured collagen, and that the cells must actually be growing on a native collagen substrate for ESAF to stimulate cell growth. This conclusion is consistent with the results obtained in other experiments in which ESAF had no effect on CBEC growing on plastic dishes with a collagen gel floating in the medium above the cells (data not shown). The floating collagen gels were either preincubated with ESAF or ESAF was added to the cultures at the same time as the gel.
Effect of ESAF on fibroblasts
Human enibryo and adult skin fibroblasts showed no response to ESAF when tested under the same conditions as CBEC (data not shown).
DISCUSSION
We have previously reported ESAF is angiogenic when assayed on the chick chorioallantoic membrane (Weiss et al., 1979) and we have shown that it stimulates endothelial-cell (CBEC) proliferation on native collagen gels in vitro without addition of human platelet factors to the cultures. Unlike some TAFcontaining tumour extracts ESAF does not stimulate fibroblast growth.
The data presented in Fig. 3 indicate that the response of the endothelial cells to ESAF can be influenced by the concentrations of serum in the medium. We are currently investigating whether this effect is due to bovine platelet factors in the serum. It has been shown, however, that growth factors derived from human serum and platelets are immunologically different from bovine serum factors (Antoniades & Scher, 1978) .
The stimulation of CBEC proliferation on native collagen gels in vitro by all of the batches of ESAF tested (9 in total) shows a similar bell-shaped dose-response curve. CBEC cultured on either plastic culture dishes or denatured collagen films showed no response to ESAF under any of the conditions tested. Our data show that ESAF-bound collagen stimulates cell proliferation only when used as the substrate for the cells. ESAF bound to collagen was not removed by extensive washing with 0-5M PBS, thus the binding does not seem to be a simple electrostatic attachment.
The importance of the extracellular matrix in cell behaviour is widely recognized. Collagen is a major constituent of the extracellular matrix and it has been shown to affect cell attachment (Schor & Court, 1979; Klebe, 1975; Murray et al., 1979) proliferation (Liotta et al., 1978; Schor, 1980; Rath & Reddi, 1979; Gey et al., 1974; Ehrman & Gey, 1956) migration (Algire & Chalkley, 1945; Kadish et al., 1979) , differentiation (Reddi & Anderson, 1976; Meier & Hay, 1975; Konigsberg & Hauschka, 1965) morphology and collagen biosynthesis (Meier & Hay, 1974) . New formation of collagen, as well as neovascularization, are required for continuous tumour growth; both the tumourassociated collagen and blood vessels are produced by the host (Folkman 1974; Gullino, 1973) . It is therefore possible that a native collagen substrate allows the CBEC to react to ESAF as they would in vivo, whereas more artificial substrates such as plastic or denatured collagen do not. Chemical identification of the many angiogenic factors reported in the literature (Folkman et al. 1971; , Phillips et al., 1976; McAuslan & Hoffman, 1979; Polverini et al., 1977; Wolf & Harrison, 1973; Klagsburn et al., 1976; Auerbach et al., 1976; Huseby et al., 1975; Maiorana & Gullino, 1978; Tsukamoto & Sugino, 1979; Gospodarowicz & Thakral, 1978) including our own will determine whether they are the same. Published data suggest that TAF is a unique tumour marker (Algire & Chalkley, 1945; Folkman, 1974; Phillips et al., 1976; Maiorana & Gullino, 1978) but it may be the same as other angiogenic factors, possibly common to all tissue capable of growth and repair, its concentration related to the metabolic activity of the tissue. It is worth pointing out that the 797 angiogenic factor used in our experiments (ESAF) was in fact tumour-derived. It will be interesting to know whether the reported lack of stimulatory activity by other purified angiogenic factors when tested on endothelial cells in vitro (MeAuslan & Hoffman, 1979; Folkman, in Kumar, 1980) does also apply when the cells are cultured on native collagen, and whether endothelial cells derived from capillaries and from large vessels can be stimulated in a similar way by ESAF in culture.
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